Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma - Concepedia

Concepedia

Publication | Open Access

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

DOI Full Paper Access

50

Citations

10

References

2017

Year

Joaquín Martínez‐López, Beatriz Sánchez-Vega, Santiago Barrio, Isabel Cuenca, Yanira Ruiz‐Heredia, Rafael Alonso, Inmaculada Rapado, Constanza Celia Nieto Marín, M-T Cedena, Bruno Paiva,

EngineeringGeneticsPathologyMolecular GeneticsCell DifferentiationClinical ValidationEpigeneticsProtein SynthesisMyeloid NeoplasiaOncogenic Differentiation BlockHematological MalignancyAltered Ribosomal BiogenesisHematologyMolecular DiagnosticsRadiation OncologyRna ProcessingCancer ResearchPhase Ii TrialMedicineRna BiologyBiomedical AnalysisGene ExpressionCell BiologySequencingDevelopmental BiologyMultiple MyelomaOncology

Abstract

support for the investigation of the contribution of altered ribosomal biogenesis to an oncogenic differentiation block.

References

	Year	Citations

Page 1